100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Previously searched by you
Previously searched by you
logo
NURS 6565 FNP Review-AANP $15.49   Add to cart
Quickly navigate to
Preview
  2.  
  3. NURS Walden
  4.  
  5. NURS Walden

Exam (elaborations)

NURS 6565 FNP Review-AANP
 3 views  0 purchase
  • Course
  • NURS Walden
  • Institution
  • NURS Walden

NURS 6565 FNP Review-AANP, Walden University

Preview 4 out of 94  pages

Document information

  • September 8, 2023
  • 94
  • 2023/2024
  • Exam (elaborations)
  • Questions & answers

Subjects

  • nurs 6565 fnp review aanp
  • walden university

Written for

  • NURS Walden
All documents for this subject (244)

Seller

avatar-seller
NURSwalden

Reviews received

Content preview

NURS 6565 FNP Review - AANP

, PREVENTION/HEALTH PROMOTION/IMMUNIZATION


LEVEL OF PREVENTION IMMUNIZATION PEARLS SMOKING - PACK YEAR HX
➢ PRIMARY HX of Anaphylactic Immunization to avoid Number of packs-per-day (PPD)
o Goal: preventing the health problem, the reaction Multiplied by # of years smoked
most cost-effective form of healthcare Neomycin IPV, MMR, varicella
o Example: immunizations, counseling about Streptomycin, IPV, smallpox
safety, injury and disease prevention polymyxin B, neomycin 5 A’S OF SMOKING CESSATION
➢ SECONDARY Baker’s yeast Hepatitis B 1. Ask about tobacco use
o Goal: detecting disease in early, Gelatin, neomycin Varicella zoster
2. Advise to quit
asymptomatic, or preclinical state to minimize Gelatin MMR
3. Assess willingness to make a quit
its impact
o Example: screening tests, such as BP check, Previously unvaccinated adults age 19-59 with attempt
mammography, colonoscopy, ASA in hx MI diabetes should be vaccinated against Hepatitis B 4. Assist in quit attempt
➢ TERTIARY LIVE VACCINES 5. Arrange follow-up
o Goal: minimizing negative disease induced o MMR
outcomes ▪ Patients born before 1957 have
o Example: in established disease, adjusting likelihood of immunity due to PNEUMOCOCCAL IMMUNIZATION
therapy to avoid further target organ damage. natural infection
➢ PCV13 associated with greater
Potentially viewed as a failure of primary ▪ Two doses 1 month apart for
prevention, support groups those never immunized immunogenicity
o Varicella ➢ PPSV23 not licensed for children
o Zostavax under 2
IMMUNIZATION PRINCIPLES o Intranasal Flu Mist ➢ Indications: chronic lung disease,
➢ Community (herd immunity) ➢ Avoid these with Pregnancy, immune suppression chronic cardiovascular disease,
o Immunize those who can be to protect those and with HIV (CD4 count < 200) – case by case diabetes, chronic liver disease,
who cannot be immunized situation
chronic alcohol abuse, smokers,
➢ Active immunity ➢ Rotavirus
o Avoid with SCID (severe combined malignancy, chronic renal failure,
o Resistance developed in response to an
immunodeficiency) asplenia, sickle cell,
antigen (either infection or vaccine)
immunocompromised, HIV.
➢ Passive immunity
o Immunity conferred by an antibody produced HEPATITIS B ➢ PCV13 followed by PPSV23 one year
in another host (infant of mother or immune ➢ Chronic Hep B can lead to hepatocellular later and then again at 65
globulin carcinoma, cirrhosis and continued infectivity o Exception: HIV (8 weeks
later)
➢ Childhood Hep B vaccines began in 1982
Immunize unless sending to the hospital in an ambulance
➢ 3 dose series 0, 1, 6 months ➢ If PPSV23 before age 65, repeat in 5
➢ If not vaccinated and exposed – HBIG and series years
➢ If vaccinated and exposed – single dose vaccine

, PREVENTION/HEALTH PROMOTION/IMMUNIZATION
TETANUS
VARICELLA ➢ Infection caused by Clostridium
SMALLPOX
➢ Live virus; 2 dose series starting > 1 year of age tetani – found in soil lead to lockjaw
➢ Caused by variola virus
➢ Although highly protective, mild cases of chicken ➢ If no previous immunity - give Tdap
➢ Infective droplets – contagious during fever, but
pox have been associated with the disease followed by Td in 1 and 6 months
most contagious during rash
➢ Varicella antibody titers should be ordered on a ➢ Need vaccine every 10 years with a
o Contagious until last scab falls off
healthcare worker who had chicken pox as a child single dose of Tdap in adulthood
➢ Stopped vaccinating in 1972
➢ Varicella Zoster Immune Globulin (VZIG) is made ➢ If dirty wound – BOOST if not TD in
➢ Incubation period 7-17 days
of pooled blood product with excellent safety 5 years (Tdap and Immunoglobin if
➢ Prodromal stage – fever, malaise, headaches,
rating (given if contraindications for vaccine) no previous vaccine)
body aches
➢ Pregnant women without immunity should be
➢ Rash starts on face > arms/legs > hands/feet
vaccinated with two doses after giving birth
o All lesions within same phase and spreads HEPATITIS A
➢ Varicella is transmitted via droplet
within 24 hours ➢ Peak infectivity occurs the 2-week
➢ Vaccination within 3-5 days of exposure has
➢ Vaccination within 3 days of exposure reduces period before the onset of jaundice
shown benefits to reduce disease
severity or elevated liver enzymes
➢ Vaccinia – unique immunization method ➢ Approximately 50% of cases have
o 2-pronged needle dipped into vaccine and no specific risk factors identified
then pricks skin STAGES OF CHANGE MODEL
➢ PRECONTEMPLATION ➢ When traveling to developing
o Not interested or minimalizes nations, avoid foods that are eaten
➢ CONTEMPLATION raw
POLIOVIRUS
o Considering change, looks at positive and ➢ Administer 4-6 weeks prior to
➢ Transmission is fecal-oral
negative, feels “stuck” traveling to an area where disease is
➢ PREPARATION endemic
SENSITIVITY AND SPECIFICITY o Exhibits some change behaviors, but does ➢ Treatment is supportive
➢ Sensitivity – ability of a test to detect a person not have tools to proceed
who has disease (SEN rule in) ➢ ACTION SHINGLES VACCINE
➢ Specificity – ability of a test to detect a person o Ready to go forward, takes concrete ➢ Recommended for everyone except
who is healthy (SPOUT – rule out) steps, but no consistency those contraindicated
➢ MAINTENANCE/RELAPSE ➢ Infectious until lesions dry/crusted
o Learns to continue the change and ➢ Zostavax
embraced the healthy habit o Live; One-time dose age 60
➢ Shingrix
o Non-live; 2 doses age 50
o Preferred vaccine

, PREVENTION/HEALTH PROMOTION/IMMUNIZATION

➢ Prostate Cancer
US PREVENTATIVE SERVICES TASK FORCE CANCER PREVALENCE
o Benefits of PSA screening do not
➢ Aspirin use to prevent cardiovascular disease and ➢ Skin cancer is most common cancer
outweigh the disadvantages
colorectal cancer o Basal cell carcinoma
o Risk factors:
o Age 50-59 with >10% ASCVD o Melanoma highest mortality
▪ Age > 50
➢ Breast Cancer ➢ Men – prostate cancer
▪ African ancestry
o Mammography age 50-74 (every 2 years) ➢ Women – breast cancer
▪ First degree relative
o Risk factors (start age 40 or BRCA1/2) ➢ Gynecological
➢ Ovarian Cancer
▪ Previous hx of breast cancer o Uterine/endometrial
o Routine screening not recommended
▪ >2 first-degree relatives o Ovarian
o BRCA1/BRCA2 mutations – refer to
▪ Early menarche, late menopause, ➢ Children – acute lymphoblastic
specialist
nulliparity leukemia (ALL)
➢ Skin Cancer Counseling
▪ obesity
o Recommend for those with fair skin
➢ Cervical Cancer
➢ Abdominal Aortic Aneurysm
o Age 21 – screen every 3 years
o Men age 65-75 who have smoked
o Age 30 – screen with HPV every 5 years
o One-time ultrasound MORTALITY
o Hysterectomy with removal of cervix –
➢ Lipid Disorders ➢ Leading cause of death (all ages)
only need screening if hysterectomy due
o Start low – moderate statin when all: o Heart disease
to cervical cancer
▪ Age 40-74 o Cancer
o Stop screening at age 65
▪ CVD risk factor ▪ Men (lung,
o Risk factors:
▪ ASCVD > 10% prostate, colorectal)
▪ Multiple sex partners
➢ Lung Cancer ▪ Women (lung,
▪ Younger age at onset of sex
o Smoke 30 pack-years or quit in last 15 breast, colorectal)
▪ Immunosuppression and smoker
years o Chronic respiratory
➢ Colorectal Cancer
o Age 55-80 (annual screening with CT)
o Start age 50-75
▪ Colonoscopy every 10 years
OVARIAN CANCER ADOLESCENTS
▪ Flex sigmoidoscopy or CT
➢ Death rate for teen males is higher
colonography every 5 years ➢ No recommendation for routine screening
than females
▪ FOBT (3 consecutive stool ➢ In postmenopausal women with palpable ovary
o Accidents (MVC most
samples) annually o Intravaginal ultrasound and CA-125
common)
▪ New Cologuard ➢ Strongest risk factor is BRCA1 or BRCA2
o Suicide
o Risk Factors ➢ Other risk factors include age, obesity, Clomid
o Homicide
▪ Familial polyposis use or endometriosis
▪ First degree relative w/ colon CA ➢ Prostate/testicular cancer screening not
▪ Crohn’s (ulcerative colitis) recommended

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller NURSwalden. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $15.49. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

78998 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling

Recently viewed by you

Summary ·

(0)

Chapter 28 Review

$15.49
  • (0)
  Add to cart